Your browser doesn't support javascript.
loading
Plasma proteomics analysis of patients with chronic spontaneous urticaria reveals significant associations with key disease characteristics but not with response to omalizumab treatment.
Ghazanfar, Misbah Noshela; Petrosius, Valdemaras; Sørensen, Jennifer Astrup; Zhang, Ditte Georgina; Ali, Zarqa; Maurer, Marcus; Kocatürk, Emek; Nielsen, Valdemar Wendelboe; Savickas, Simonas; Keller, Ulrich Auf dem; Schoof, Erwin M; Thomsen, Simon Francis.
Afiliación
  • Ghazanfar MN; Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark.
  • Petrosius V; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Sørensen JA; Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark.
  • Zhang DG; Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark.
  • Ali Z; Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark.
  • Maurer M; Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Kocatürk E; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • Nielsen VW; Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Savickas S; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
  • Keller UAD; Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.
  • Schoof EM; Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark.
  • Thomsen SF; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Allergy ; 79(9): 2547-2550, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38798066

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antialérgicos / Proteómica / Omalizumab / Urticaria Crónica Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Allergy Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Dinamarca

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antialérgicos / Proteómica / Omalizumab / Urticaria Crónica Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Allergy Año: 2024 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Dinamarca